| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.38e-09 | 5 | 83 | 4 | GO:0050649 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 1.92e-08 | 8 | 83 | 4 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 8.96e-08 | 11 | 83 | 4 | GO:0101020 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.69e-07 | 14 | 83 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 2.76e-07 | 4 | 83 | 3 | GO:0008390 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 6.88e-07 | 5 | 83 | 3 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 6.88e-07 | 5 | 83 | 3 | GO:0062181 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 1.37e-06 | 6 | 83 | 3 | GO:0070576 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.37e-06 | 6 | 83 | 3 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 2.39e-06 | 7 | 83 | 3 | GO:0070643 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 3.82e-06 | 8 | 83 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 3.82e-06 | 8 | 83 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 1.17e-05 | 34 | 83 | 4 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.32e-05 | 35 | 83 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 1.38e-05 | 189 | 83 | 7 | GO:0004721 | |
| GeneOntologyMolecularFunction | histone binding | 1.45e-05 | 265 | 83 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 3.04e-05 | 15 | 83 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 3.20e-05 | 386 | 83 | 9 | GO:0042578 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 4.52e-05 | 17 | 83 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 4.52e-05 | 17 | 83 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 5.10e-05 | 49 | 83 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | iron ion binding | 6.71e-05 | 166 | 83 | 6 | GO:0005506 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.58e-04 | 194 | 83 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | phosphatase activity | 1.92e-04 | 287 | 83 | 7 | GO:0016791 | |
| GeneOntologyMolecularFunction | oxygen binding | 4.86e-04 | 37 | 83 | 3 | GO:0019825 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 6.03e-04 | 9 | 83 | 2 | GO:0010854 | |
| GeneOntologyMolecularFunction | demethylase activity | 8.11e-04 | 44 | 83 | 3 | GO:0032451 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 8.98e-04 | 103 | 83 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.35e-03 | 115 | 83 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 1.86e-03 | 807 | 83 | 10 | GO:0016788 | |
| GeneOntologyMolecularFunction | steroid binding | 2.30e-03 | 133 | 83 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 2.50e-03 | 18 | 83 | 2 | GO:0010851 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.54e-03 | 739 | 83 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | heme binding | 3.90e-03 | 154 | 83 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 4.87e-03 | 164 | 83 | 4 | GO:0046906 | |
| GeneOntologyBiologicalProcess | gonadal mesoderm development | 2.94e-13 | 9 | 83 | 6 | GO:0007506 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 3.02e-08 | 9 | 83 | 4 | GO:0002933 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 1.18e-07 | 12 | 83 | 4 | GO:0070989 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 6.25e-07 | 5 | 83 | 3 | GO:0009822 | |
| GeneOntologyBiologicalProcess | demethylation | 2.44e-06 | 24 | 83 | 4 | GO:0070988 | |
| GeneOntologyBiologicalProcess | alkaloid metabolic process | 5.19e-06 | 9 | 83 | 3 | GO:0009820 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 9.85e-06 | 122 | 83 | 6 | GO:0006334 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.99e-05 | 40 | 83 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 2.34e-05 | 142 | 83 | 6 | GO:0034728 | |
| GeneOntologyBiologicalProcess | lipid modification | 2.50e-05 | 214 | 83 | 7 | GO:0030258 | |
| GeneOntologyBiologicalProcess | mesoderm development | 4.11e-05 | 157 | 83 | 6 | GO:0007498 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 5.70e-05 | 52 | 83 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 1.26e-04 | 372 | 83 | 8 | GO:0060485 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.63e-04 | 141 | 83 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 2.75e-04 | 222 | 83 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | aflatoxin metabolic process | 4.41e-04 | 8 | 83 | 2 | GO:0046222 | |
| GeneOntologyBiologicalProcess | mycotoxin metabolic process | 4.41e-04 | 8 | 83 | 2 | GO:0043385 | |
| GeneOntologyBiologicalProcess | organic heteropentacyclic compound metabolic process | 4.41e-04 | 8 | 83 | 2 | GO:1901376 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 4.42e-04 | 37 | 83 | 3 | GO:0042178 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 4.59e-04 | 89 | 83 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | dephosphorylation | 4.99e-04 | 347 | 83 | 7 | GO:0016311 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 5.06e-04 | 249 | 83 | 6 | GO:0065004 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 5.65e-04 | 94 | 83 | 4 | GO:0016101 | |
| Domain | Cyt_P450_E_grp-II | 1.40e-09 | 5 | 78 | 4 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 4.19e-09 | 6 | 78 | 4 | IPR008072 | |
| Domain | ConA-like_dom | 3.61e-05 | 219 | 78 | 7 | IPR013320 | |
| Domain | MAM_1 | 3.77e-05 | 16 | 78 | 3 | PS00740 | |
| Domain | NAP | 4.57e-05 | 17 | 78 | 3 | PF00956 | |
| Domain | NAP_family | 4.57e-05 | 17 | 78 | 3 | IPR002164 | |
| Domain | MAM | 4.57e-05 | 17 | 78 | 3 | SM00137 | |
| Domain | MAM | 5.47e-05 | 18 | 78 | 3 | PF00629 | |
| Domain | MAM_dom | 5.47e-05 | 18 | 78 | 3 | IPR000998 | |
| Domain | MAM_2 | 5.47e-05 | 18 | 78 | 3 | PS50060 | |
| Domain | Cyt_P450_CS | 7.06e-05 | 53 | 78 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 9.40e-05 | 57 | 78 | 4 | PS00086 | |
| Domain | p450 | 1.01e-04 | 58 | 78 | 4 | PF00067 | |
| Domain | Cyt_P450 | 1.15e-04 | 60 | 78 | 4 | IPR001128 | |
| Domain | ZF_CCHHC | 3.57e-04 | 7 | 78 | 2 | PS51802 | |
| Domain | PTPc | 4.53e-04 | 36 | 78 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.75e-04 | 39 | 78 | 3 | PS50055 | |
| Domain | fn3 | 5.85e-04 | 162 | 78 | 5 | PF00041 | |
| Domain | MBT | 6.08e-04 | 9 | 78 | 2 | SM00561 | |
| Domain | MBT | 6.08e-04 | 9 | 78 | 2 | PS51079 | |
| Domain | PTPase_domain | 6.66e-04 | 41 | 78 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 6.66e-04 | 41 | 78 | 3 | PF00102 | |
| Domain | MBT | 7.58e-04 | 10 | 78 | 2 | PF02820 | |
| Domain | Mbt | 7.58e-04 | 10 | 78 | 2 | IPR004092 | |
| Domain | Cyt_P450_E_grp-I | 8.76e-04 | 45 | 78 | 3 | IPR002401 | |
| Domain | FN3 | 1.06e-03 | 185 | 78 | 5 | SM00060 | |
| Domain | FN3 | 1.47e-03 | 199 | 78 | 5 | PS50853 | |
| Domain | FN3_dom | 1.82e-03 | 209 | 78 | 5 | IPR003961 | |
| Domain | - | 1.83e-03 | 58 | 78 | 3 | 1.10.630.10 | |
| Domain | PTPc_motif | 1.93e-03 | 59 | 78 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.93e-03 | 59 | 78 | 3 | IPR003595 | |
| Domain | Tyr_Pase_AS | 3.53e-03 | 73 | 78 | 3 | IPR016130 | |
| Domain | Pentatricopeptide_repeat | 4.12e-03 | 23 | 78 | 2 | IPR002885 | |
| Domain | TYR_PHOSPHATASE_1 | 5.59e-03 | 86 | 78 | 3 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 5.77e-03 | 87 | 78 | 3 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 5.77e-03 | 87 | 78 | 3 | IPR000387 | |
| Domain | SAM | 5.96e-03 | 88 | 78 | 3 | SM00454 | |
| Domain | - | 6.74e-03 | 92 | 78 | 3 | 3.90.190.10 | |
| Domain | Galactose-bd-like | 7.15e-03 | 94 | 78 | 3 | IPR008979 | |
| Domain | SAM_DOMAIN | 7.36e-03 | 95 | 78 | 3 | PS50105 | |
| Domain | - | 7.36e-03 | 95 | 78 | 3 | 2.60.120.200 | |
| Domain | SAM | 7.80e-03 | 97 | 78 | 3 | IPR001660 | |
| Domain | Prot-tyrosine_phosphatase-like | 8.25e-03 | 99 | 78 | 3 | IPR029021 | |
| Pathway | REACTOME_XENOBIOTICS | 1.38e-06 | 23 | 52 | 4 | M5372 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 2.62e-06 | 8 | 52 | 3 | MM1547 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 3.65e-06 | 29 | 52 | 4 | M2920 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.02e-05 | 12 | 52 | 3 | MM15616 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.09e-05 | 15 | 52 | 3 | MM15697 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.62e-05 | 51 | 52 | 4 | M17726 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.71e-05 | 18 | 52 | 3 | MM14843 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.91e-05 | 104 | 52 | 5 | M738 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 4.89e-05 | 55 | 52 | 4 | M14933 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 6.94e-05 | 22 | 52 | 3 | MM15614 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 7.84e-05 | 62 | 52 | 4 | M39653 | |
| Pathway | REACTOME_PREDNISONE_ADME | 7.96e-05 | 23 | 52 | 3 | MM16639 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 8.88e-05 | 64 | 52 | 4 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 8.88e-05 | 64 | 52 | 4 | M9488 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 9.07e-05 | 24 | 52 | 3 | M46445 | |
| Pathway | REACTOME_XENOBIOTICS | 1.03e-04 | 25 | 52 | 3 | MM14846 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 1.16e-04 | 26 | 52 | 3 | MM15190 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.26e-04 | 70 | 52 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.41e-04 | 72 | 52 | 4 | M9257 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 2.18e-04 | 32 | 52 | 3 | M39567 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 2.39e-04 | 33 | 52 | 3 | MM1448 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 5.98e-04 | 105 | 52 | 4 | MM14842 | |
| Pathway | REACTOME_ASPIRIN_ADME | 6.02e-04 | 45 | 52 | 3 | MM15694 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 8.60e-04 | 12 | 52 | 2 | M39611 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR | 1.18e-03 | 14 | 52 | 2 | M47975 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.27e-03 | 220 | 52 | 5 | M10320 | |
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 1.50e-10 | 5 | 83 | 4 | 11266076 | |
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 1.05e-09 | 7 | 83 | 4 | 11137287 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 37258238 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 28567424 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 23846873 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 25005602 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 11284050 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 14733933 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 12147261 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 21081028 | ||
| Pubmed | Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone. | 1.31e-08 | 3 | 83 | 3 | 1339292 | |
| Pubmed | Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. | 1.31e-08 | 3 | 83 | 3 | 12617959 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 19801957 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 9143324 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 1.31e-08 | 3 | 83 | 3 | 23143891 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 33866277 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 20621111 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 1.31e-08 | 3 | 83 | 3 | 20615193 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 22291988 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 15548719 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 11726664 | ||
| Pubmed | CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism. | 1.31e-08 | 3 | 83 | 3 | 21148252 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 23370405 | ||
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 1.31e-08 | 3 | 83 | 3 | 32001245 | |
| Pubmed | Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. | 1.31e-08 | 3 | 83 | 3 | 2402224 | |
| Pubmed | High fat diet induced obesity is mitigated in Cyp3a-null female mice. | 1.31e-08 | 3 | 83 | 3 | 29738703 | |
| Pubmed | A novel female-specific member of the CYP3A gene subfamily in the mouse liver. | 1.31e-08 | 3 | 83 | 3 | 10775455 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 32146629 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 19226368 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 7932176 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 19188337 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 17582393 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 20118548 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 34688813 | ||
| Pubmed | Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism. | 1.31e-08 | 3 | 83 | 3 | 26212543 | |
| Pubmed | Sequence diversity and haplotype structure at the human CYP3A cluster. | 2.12e-08 | 13 | 83 | 4 | 16314882 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 21088200 | ||
| Pubmed | Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors. | 5.23e-08 | 4 | 83 | 3 | 12958193 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 36050438 | ||
| Pubmed | A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver. | 5.23e-08 | 4 | 83 | 3 | 7813478 | |
| Pubmed | Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. | 5.23e-08 | 4 | 83 | 3 | 17975676 | |
| Pubmed | Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice. | 5.23e-08 | 4 | 83 | 3 | 31633069 | |
| Pubmed | Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans. | 5.23e-08 | 4 | 83 | 3 | 27638959 | |
| Pubmed | Humanized xenobiotic response in mice expressing nuclear receptor SXR. | 5.23e-08 | 4 | 83 | 3 | 10935643 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 10230766 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 34689350 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 18978522 | ||
| Pubmed | Knockout of mouse Cyp3a gene enhances synthesis of cholesterol and bile acid in the liver. | 5.23e-08 | 4 | 83 | 3 | 23709690 | |
| Pubmed | Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model. | 5.23e-08 | 4 | 83 | 3 | 26903378 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 32130917 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 25319358 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 17936928 | ||
| Pubmed | The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice. | 5.23e-08 | 4 | 83 | 3 | 30796914 | |
| Pubmed | Mouse aortic muscle cells respond to oxygen following cytochrome P450 3A13 gene transfer. | 5.23e-08 | 4 | 83 | 3 | 23656416 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 7803471 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 14509827 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 23125282 | ||
| Pubmed | Sterol 27-hydroxylase gene dosage and the antiatherosclerotic effect of Rifampicin in mice. | 1.31e-07 | 5 | 83 | 3 | 29191818 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 24168324 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 14559847 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 19920203 | ||
| Pubmed | Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures. | 1.31e-07 | 5 | 83 | 3 | 29125184 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 23090875 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 18156313 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 8006463 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 32087611 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 11093772 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 29725048 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 1.42e-07 | 20 | 83 | 4 | 9890157 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 21351274 | ||
| Pubmed | Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice. | 2.61e-07 | 6 | 83 | 3 | 22503787 | |
| Pubmed | Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol. | 2.61e-07 | 6 | 83 | 3 | 8043019 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 14642533 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 26265742 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 21193583 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 20926756 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 15930522 | ||
| Pubmed | Effects of infection of MRSA on the expression and activity of renal cytochrome P450s in mice. | 4.56e-07 | 7 | 83 | 3 | 30944282 | |
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 19842932 | ||
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 27514509 | ||
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 27137100 | ||
| Pubmed | Joint effects of inflammation and androgen metabolism on prostate cancer severity. | 4.56e-07 | 7 | 83 | 3 | 18566991 | |
| Pubmed | A novel transmembrane MSP-containing protein that plays a role in right ventricle development. | 4.56e-07 | 7 | 83 | 3 | 15533722 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 18794335 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 30910785 | ||
| Pubmed | Identification and characterization of human FNBP3 gene in silico. | 7.28e-07 | 8 | 83 | 3 | 12964049 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 20147896 | ||
| Pubmed | Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. | 7.28e-07 | 8 | 83 | 3 | 18488193 | |
| Pubmed | 7.88e-07 | 30 | 83 | 4 | 20529763 | ||
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 3917435 | ||
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 7678494 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 12865317 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 26165599 | ||
| Pubmed | Role of the Drug-Metabolizing Enzyme CYP during Mouse Liver Development. | 2.13e-06 | 11 | 83 | 3 | 27904043 | |
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 15319333 | ||
| Pubmed | Next-generation sequencing to generate interactome datasets. | ARHGAP1 ST6GAL2 PLLP TCAF1 RUNDC3A TAX1BP1 RCOR3 WDFY3 TSSC4 MAPK9 CHN1 L3MBTL3 PTCD3 | 3.18e-06 | 1147 | 83 | 13 | 21516116 |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27225724 | ||
| Pubmed | Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip. | 5.63e-06 | 2 | 83 | 2 | 16207150 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28986474 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28704257 | ||
| Cytoband | Yp11.2 | 2.08e-08 | 94 | 83 | 6 | Yp11.2 | |
| Cytoband | 7q21.1 | 3.17e-07 | 8 | 83 | 3 | 7q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYp11 | 3.38e-07 | 150 | 83 | 6 | chrYp11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 3.06e-06 | 219 | 83 | 6 | chr7q22 | |
| Cytoband | 17p13.2 | 4.51e-03 | 55 | 83 | 2 | 17p13.2 | |
| GeneFamily | Cytochrome P450 family 3 | 3.59e-09 | 8 | 50 | 4 | 1002 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.56e-05 | 21 | 50 | 3 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 7.83e-05 | 160 | 50 | 5 | 555 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 2.67e-04 | 9 | 50 | 2 | 1263 | |
| GeneFamily | Sterile alpha motif domain containing | 1.85e-03 | 88 | 50 | 3 | 760 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 8.11e-03 | 49 | 50 | 2 | 584 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 8.44e-03 | 50 | 50 | 2 | 721 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.03e-06 | 200 | 83 | 6 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.03e-06 | 200 | 83 | 6 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 160 | 83 | 5 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 178 | 83 | 5 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 186 | 83 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-05 | 192 | 83 | 5 | 56f2388c9c4e19883ae5cff332c77f596ff744a8 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.05e-05 | 193 | 83 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-05 | 196 | 83 | 5 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.37e-05 | 197 | 83 | 5 | 1378bf90a4b80b8166ef352c282ce51b114ba693 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-05 | 198 | 83 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 198 | 83 | 5 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 198 | 83 | 5 | 8fac96132663f54566136ef54b53684d31dfde32 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 198 | 83 | 5 | c506334d81af672ef9ddc8c4fd2a790bdb58e63e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 198 | 83 | 5 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 198 | 83 | 5 | c48b3f026b16d48b8eca9f74dc1e3f3f39a89322 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 198 | 83 | 5 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 199 | 83 | 5 | 47466253069d4b1b8f13ce3210f434e60753b38a | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 199 | 83 | 5 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.55e-05 | 99 | 83 | 4 | 4f0346fe85ba006d1ab28a61624568522ffe5cb4 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Cck_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.95e-05 | 129 | 83 | 4 | 08ecebb7f09d105dfdfd2191fc310910d3baec0f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 148 | 83 | 4 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 154 | 83 | 4 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.22e-04 | 159 | 83 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-04 | 163 | 83 | 4 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-04 | 163 | 83 | 4 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 166 | 83 | 4 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-04 | 167 | 83 | 4 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.74e-04 | 168 | 83 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.87e-04 | 170 | 83 | 4 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythroid_lineage_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-04 | 170 | 83 | 4 | 288014dedda8babc51fe08e48a55e68d83e1b1d2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.87e-04 | 170 | 83 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 2.87e-04 | 170 | 83 | 4 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-04 | 172 | 83 | 4 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 173 | 83 | 4 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 174 | 83 | 4 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-04 | 174 | 83 | 4 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-04 | 174 | 83 | 4 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.13e-04 | 174 | 83 | 4 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 177 | 83 | 4 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.48e-04 | 179 | 83 | 4 | b1f085e4c8d65d5cdbfaf2db80343638abb08979 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 180 | 83 | 4 | 0059e5acade6c895fd629767bea1c15f40b0d1b0 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 180 | 83 | 4 | dfb8412e1e06fa7349e66eea2ef27d9ea98b7893 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.63e-04 | 181 | 83 | 4 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 181 | 83 | 4 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 3.63e-04 | 181 | 83 | 4 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 183 | 83 | 4 | 91764095f7ea4bc806ef6c7b841fc5e5e90faf5f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.79e-04 | 183 | 83 | 4 | 9dfb398b9995d562864fe688861a831ada0814cd | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-04 | 184 | 83 | 4 | 382b1e90b3f437af596750669c0465a169d97095 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-04 | 185 | 83 | 4 | c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.03e-04 | 186 | 83 | 4 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 186 | 83 | 4 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 186 | 83 | 4 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.03e-04 | 186 | 83 | 4 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.11e-04 | 187 | 83 | 4 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.11e-04 | 187 | 83 | 4 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-04 | 187 | 83 | 4 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.19e-04 | 188 | 83 | 4 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | wk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.19e-04 | 188 | 83 | 4 | d3d7d21d4fa39ac4106a164652673de1bef8662d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.28e-04 | 189 | 83 | 4 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-04 | 189 | 83 | 4 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 4.36e-04 | 190 | 83 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.36e-04 | 190 | 83 | 4 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-04 | 190 | 83 | 4 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-04 | 190 | 83 | 4 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 4.45e-04 | 191 | 83 | 4 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.45e-04 | 191 | 83 | 4 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-04 | 191 | 83 | 4 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.45e-04 | 191 | 83 | 4 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-04 | 191 | 83 | 4 | c7b95a5f9185d533c08754ce2e4ce91533eb612e | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.45e-04 | 191 | 83 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 191 | 83 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-04 | 192 | 83 | 4 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 4.54e-04 | 192 | 83 | 4 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 4.54e-04 | 192 | 83 | 4 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.54e-04 | 192 | 83 | 4 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | Influenza_Severe-RBC|Influenza_Severe / Disease group and Cell class | 4.54e-04 | 192 | 83 | 4 | f19b6da3fd98da1a76d2570137a8f73a3850ebcb | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.54e-04 | 192 | 83 | 4 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.63e-04 | 193 | 83 | 4 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-04 | 193 | 83 | 4 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 193 | 83 | 4 | 5b30bbb354c69f684a1c8d2c68e9b3424d759e8d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 193 | 83 | 4 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 193 | 83 | 4 | ee91a796d0f6d4cee7a93a525689e716fdceeda5 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-04 | 193 | 83 | 4 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-04 | 194 | 83 | 4 | 15224fb3e7ca5bd1fb8c41f8275842f737014095 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-04 | 194 | 83 | 4 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-04 | 194 | 83 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-04 | 194 | 83 | 4 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-late_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.72e-04 | 194 | 83 | 4 | 23b06707d21306b4483d64cb350b86aef352ce38 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 195 | 83 | 4 | d6e2a5a15bea16de5f7ff09318c67d46ea923203 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 4.81e-04 | 195 | 83 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.83e-04 | 82 | 83 | 3 | 7f0ee8dafc37c3628506397f88fbb98fc6420bfb | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.83e-04 | 82 | 83 | 3 | c8242d273513e99107c154afb489980d11008555 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.91e-04 | 196 | 83 | 4 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.91e-04 | 196 | 83 | 4 | afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.91e-04 | 196 | 83 | 4 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.91e-04 | 196 | 83 | 4 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 5.00e-04 | 197 | 83 | 4 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-PNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.00e-04 | 197 | 83 | 4 | 10e72b425a2bcba35e63a5b074d3dedcd49a762e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 197 | 83 | 4 | c220102fadbb7ba385a61704a144e0b814cb5c46 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.10e-04 | 198 | 83 | 4 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| Drug | AC1L1SX8 | 3.96e-07 | 18 | 79 | 4 | CID000060278 | |
| Drug | rabeprazole | 5.00e-07 | 19 | 79 | 4 | CID000005029 | |
| Drug | Alfentanil | 7.98e-07 | 6 | 79 | 3 | ctd:D015760 | |
| Drug | BP-9,10-oxide | 2.22e-06 | 27 | 79 | 4 | CID000037456 | |
| Drug | Brn 4136738 | 2.22e-06 | 27 | 79 | 4 | CID000050331 | |
| Drug | C14845 | 2.22e-06 | 27 | 79 | 4 | CID011954064 | |
| Drug | 9-OH-BaP-4,5-oxide | 2.58e-06 | 28 | 79 | 4 | CID000115064 | |
| Drug | S 840 | 3.33e-06 | 9 | 79 | 3 | CID000096338 | |
| Drug | 19-hydroxytestosterone | 3.43e-06 | 30 | 79 | 4 | CID000150968 | |
| Drug | 11-H-14,15-EETA | 3.43e-06 | 30 | 79 | 4 | CID011954058 | |
| Drug | oxcarbazepine | 3.43e-06 | 30 | 79 | 4 | CID000034312 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 3.61e-06 | 67 | 79 | 5 | CID000015032 | |
| Drug | BP-7,8-oxide | 4.48e-06 | 32 | 79 | 4 | CID000037455 | |
| Drug | 4-hydroxymidazolam | 4.74e-06 | 10 | 79 | 3 | CID000124449 | |
| Drug | 12(13)-EpOME | 5.75e-06 | 34 | 79 | 4 | CID000001416 | |
| Drug | TCEO | 5.75e-06 | 34 | 79 | 4 | CID000028167 | |
| Drug | AC1O5XSP | 5.75e-06 | 34 | 79 | 4 | CID006442739 | |
| Drug | pantoprazole | 6.48e-06 | 35 | 79 | 4 | CID000004679 | |
| Drug | AC1L1CJI | 6.48e-06 | 35 | 79 | 4 | CID000001929 | |
| Drug | Troleandomycin | 6.50e-06 | 11 | 79 | 3 | ctd:D014217 | |
| Drug | Ticalopride | 6.50e-06 | 11 | 79 | 3 | CID000216236 | |
| Drug | 15-H-11,12-EETA | 7.27e-06 | 36 | 79 | 4 | CID011954042 | |
| Drug | AC1L3NGJ | 7.27e-06 | 36 | 79 | 4 | CID000092121 | |
| Drug | 11,14,15-THET | 1.01e-05 | 39 | 79 | 4 | CID006439531 | |
| Drug | 4-hydroxymidazolam | 1.19e-05 | 2 | 79 | 2 | ctd:C042940 | |
| Drug | norverapamil | 1.19e-05 | 2 | 79 | 2 | ctd:C016904 | |
| Drug | 5,6-dihydro-2H-pyran-2-one | 1.19e-05 | 2 | 79 | 2 | CID000520660 | |
| Drug | notopterol | 1.19e-05 | 2 | 79 | 2 | CID005320227 | |
| Drug | N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide | 1.19e-05 | 2 | 79 | 2 | ctd:C114289 | |
| Drug | 6 beta-hydroxytestosterone | 1.19e-05 | 2 | 79 | 2 | ctd:C025591 | |
| Drug | CQA 206-291 | 1.19e-05 | 2 | 79 | 2 | ctd:C059483 | |
| Drug | fructus schizandrae, radix ginseng, radix ophiopogonis drug combination | 1.19e-05 | 2 | 79 | 2 | ctd:C009252 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 1.36e-05 | 42 | 79 | 4 | CID006439610 | |
| Drug | mephenytoin | 1.38e-05 | 88 | 79 | 5 | CID000004060 | |
| Drug | propionanilide | 1.42e-05 | 14 | 79 | 3 | CID000012107 | |
| Drug | 7-BFC | 1.42e-05 | 14 | 79 | 3 | CID000848780 | |
| Drug | 9-hydroxyellipticine | 1.42e-05 | 14 | 79 | 3 | CID000091643 | |
| Drug | 14(15)-EpETrE | 1.46e-05 | 89 | 79 | 5 | CID000001431 | |
| Drug | polybrominated biphenyl | 1.64e-05 | 44 | 79 | 4 | CID000042948 | |
| Drug | naphthalene-1,2-dihydrodiol | 1.80e-05 | 45 | 79 | 4 | CID000000362 | |
| Drug | AC1L1BEQ | 1.81e-05 | 93 | 79 | 5 | CID000001407 | |
| Drug | ogen | 1.96e-05 | 46 | 79 | 4 | CID000023703 | |
| Drug | C14802 | 2.14e-05 | 47 | 79 | 4 | CID011954053 | |
| Drug | nitro-L | 2.33e-05 | 48 | 79 | 4 | CID000006849 | |
| Drug | C14800 | 2.33e-05 | 48 | 79 | 4 | CID011954051 | |
| Drug | propafenone | 2.33e-05 | 98 | 79 | 5 | CID000004932 | |
| Drug | PCB 77 | 2.33e-05 | 98 | 79 | 5 | CID000036187 | |
| Drug | 19-HETE | 2.53e-05 | 49 | 79 | 4 | CID006439528 | |
| Drug | bromobenzene-3,4-oxide | 2.53e-05 | 49 | 79 | 4 | CID000108121 | |
| Drug | noralfentanil | 2.64e-05 | 17 | 79 | 3 | CID000162172 | |
| Drug | bromobenzene-2,3-oxide | 2.74e-05 | 50 | 79 | 4 | CID003036760 | |
| Drug | 6-hydroxymelatonin | 2.74e-05 | 50 | 79 | 4 | CID000001864 | |
| Drug | 1,1-dichloroethylene epoxide | 2.74e-05 | 50 | 79 | 4 | CID000119521 | |
| Drug | naphthalene epoxide | 2.96e-05 | 51 | 79 | 4 | CID000108063 | |
| Drug | aflatoxin | 3.16e-05 | 18 | 79 | 3 | CID000014421 | |
| Drug | Azamulinum | 3.16e-05 | 18 | 79 | 3 | CID003086060 | |
| Drug | Fenthion | 3.16e-05 | 18 | 79 | 3 | ctd:D005284 | |
| Drug | Fluvoxamine | 3.16e-05 | 18 | 79 | 3 | ctd:D016666 | |
| Drug | 9-hydroxybenzo(a)pyrene | 3.45e-05 | 53 | 79 | 4 | CID000028598 | |
| Drug | erythralosamine | 3.56e-05 | 3 | 79 | 2 | CID000352196 | |
| Drug | 3-methoxymorphinan | 3.56e-05 | 3 | 79 | 2 | ctd:C028657 | |
| Drug | dechloroethylcyclophosphamide | 3.56e-05 | 3 | 79 | 2 | ctd:C064445 | |
| Drug | 6 beta-hydroxydexamethasone | 3.56e-05 | 3 | 79 | 2 | CID000063050 | |
| Drug | territrem C | 3.56e-05 | 3 | 79 | 2 | CID000160306 | |
| Drug | 1-(1-phenylcyclohexyl)pyrrolidine | 3.56e-05 | 3 | 79 | 2 | CID000062436 | |
| Drug | 17-hydroxypregnenolone sulfate | 3.56e-05 | 3 | 79 | 2 | CID000152971 | |
| Drug | 1-hydroxymethylmidazolam | 3.56e-05 | 3 | 79 | 2 | ctd:C040081 | |
| Drug | 18-hydroxy-11-deoxycortisol | 3.56e-05 | 3 | 79 | 2 | CID003082415 | |
| Drug | N-acetyl-S-pentachloro-1,3-butadienylcysteine | 3.56e-05 | 3 | 79 | 2 | ctd:C049739 | |
| Drug | trichloroacetic acid | 3.57e-05 | 107 | 79 | 5 | CID000006421 | |
| Drug | dichloroacetaldehyde | 3.72e-05 | 54 | 79 | 4 | CID000006576 | |
| Drug | chloroacetyl chloride | 4.00e-05 | 55 | 79 | 4 | CID000006577 | |
| Drug | CID5475388 | 4.39e-05 | 20 | 79 | 3 | CID005475388 | |
| Drug | 1,2-dihydroxynaphthalene | 4.61e-05 | 57 | 79 | 4 | CID000011318 | |
| Drug | DETA | 4.83e-05 | 114 | 79 | 5 | CID000004284 | |
| Drug | bromoacetaldehyde | 4.94e-05 | 58 | 79 | 4 | CID000105131 | |
| Drug | 1,1-dichloroethylene | 5.65e-05 | 60 | 79 | 4 | CID000006366 | |
| Drug | 8-MOP | 5.70e-05 | 118 | 79 | 5 | CID000004114 | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.71e-05 | 193 | 79 | 6 | 4133_UP | |
| Drug | BP-4,5-oxide | 6.03e-05 | 61 | 79 | 4 | CID000037786 | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 3375_UP | |
| Drug | aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 1145_UP | |
| Drug | 2-hydroxyestradiol | 6.84e-05 | 63 | 79 | 4 | CID000009684 | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A | 6.95e-05 | 200 | 79 | 6 | 4447_UP | |
| Drug | azacyclonol | 7.10e-05 | 4 | 79 | 2 | CID000015722 | |
| Drug | hydroxytrimipramine | 7.10e-05 | 4 | 79 | 2 | CID000160610 | |
| Drug | territrem B | 7.10e-05 | 4 | 79 | 2 | CID000114734 | |
| Drug | B253 | 7.10e-05 | 4 | 79 | 2 | CID000021540 | |
| Drug | 5-methoxyflavone | 7.10e-05 | 4 | 79 | 2 | CID000094525 | |
| Drug | Ro 23-7637 | 7.10e-05 | 4 | 79 | 2 | CID000129491 | |
| Drug | N-ethyl-3-toluamide | 7.10e-05 | 4 | 79 | 2 | ctd:C454678 | |
| Drug | CQA 206-291 | 7.10e-05 | 4 | 79 | 2 | CID000146782 | |
| Drug | eucalyptol | 7.10e-05 | 4 | 79 | 2 | ctd:C010087 | |
| Drug | Docetaxel trihydrate | 7.35e-05 | 202 | 79 | 6 | CID000003143 | |
| Drug | AC1OAGGW | 7.55e-05 | 203 | 79 | 6 | CID006857364 | |
| Drug | 5-hydroxythalidomide | 7.72e-05 | 24 | 79 | 3 | ctd:C544471 | |
| Drug | piperonyl butoxide | 8.72e-05 | 67 | 79 | 4 | CID000005794 | |
| Drug | propoxyphene | 8.72e-05 | 67 | 79 | 4 | CID000010100 | |
| Drug | vitamin E succinate | 9.24e-05 | 68 | 79 | 4 | CID000020353 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 9.24e-05 | 68 | 79 | 4 | CID000001778 | |
| Disease | tacrolimus measurement | 6.82e-08 | 4 | 77 | 3 | EFO_0008458 | |
| Disease | metabolonic lactone sulfate measurement | 1.61e-07 | 19 | 77 | 4 | EFO_0800659 | |
| Disease | Torsades de Pointes | 2.01e-05 | 3 | 77 | 2 | C0040479 | |
| Disease | epiandrosterone sulfate measurement | 3.77e-05 | 25 | 77 | 3 | EFO_0021120 | |
| Disease | mental process | 4.02e-05 | 4 | 77 | 2 | EFO_0004323 | |
| Disease | estrone conjugate measurement | 4.02e-05 | 4 | 77 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 6.69e-05 | 5 | 77 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 6.69e-05 | 5 | 77 | 2 | EFO_0800569 | |
| Disease | neutropenia, response to metamizole, Drug-induced agranulocytosis | 1.00e-04 | 6 | 77 | 2 | EFO_0010971, HP_0012235, MONDO_0001475 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 1.00e-04 | 6 | 77 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 1.00e-04 | 6 | 77 | 2 | EFO_0800294 | |
| Disease | X-24574 measurement | 1.40e-04 | 7 | 77 | 2 | EFO_0800897 | |
| Disease | MASA syndrome (implicated_via_orthology) | 1.40e-04 | 7 | 77 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 1.57e-04 | 40 | 77 | 3 | C0598589 | |
| Disease | Congenital Hand Deformities | 1.86e-04 | 8 | 77 | 2 | C0018566 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 2.39e-04 | 9 | 77 | 2 | EFO_0800278 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.98e-04 | 10 | 77 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 2.98e-04 | 10 | 77 | 2 | EFO_0800289 | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 2.98e-04 | 10 | 77 | 2 | EFO_1000650, HP_0000131 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 3.64e-04 | 11 | 77 | 2 | EFO_0801531 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 3.64e-04 | 11 | 77 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 3.64e-04 | 11 | 77 | 2 | EFO_0800295 | |
| Disease | triacylglycerol 52:2 measurement | 4.07e-04 | 55 | 77 | 3 | EFO_0010414 | |
| Disease | temporal pole volume measurement | 4.36e-04 | 12 | 77 | 2 | EFO_0010334 | |
| Disease | methionine sulfone measurement | 4.36e-04 | 12 | 77 | 2 | EFO_0800072 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 4.36e-04 | 12 | 77 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 5.15e-04 | 13 | 77 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 5.15e-04 | 13 | 77 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 5.99e-04 | 14 | 77 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 5.99e-04 | 14 | 77 | 2 | EFO_0800283 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 6.90e-04 | 15 | 77 | 2 | EFO_0800301 | |
| Disease | dehydroepiandrosterone sulphate measurement | 7.58e-04 | 68 | 77 | 3 | EFO_0007001 | |
| Disease | X-21410 measurement | 7.88e-04 | 16 | 77 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 7.88e-04 | 16 | 77 | 2 | EFO_0800305 | |
| Disease | Amyotrophic lateral sclerosis | 8.91e-04 | 17 | 77 | 2 | cv:C0002736 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.00e-03 | 18 | 77 | 2 | EFO_0800288 | |
| Disease | cerebral microbleeds | 1.12e-03 | 19 | 77 | 2 | EFO_0010059 | |
| Disease | etiocholanolone glucuronide measurement | 1.12e-03 | 19 | 77 | 2 | EFO_0800362 | |
| Disease | blood urea nitrogen measurement | 1.18e-03 | 452 | 77 | 6 | EFO_0004741 | |
| Disease | androsterone glucuronide measurement | 1.24e-03 | 20 | 77 | 2 | EFO_0800317 | |
| Disease | X-24947 measurement | 1.50e-03 | 22 | 77 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 1.50e-03 | 22 | 77 | 2 | EFO_0021115 | |
| Disease | antiphospholipid syndrome | 1.79e-03 | 24 | 77 | 2 | EFO_0002689 | |
| Disease | brain cancer (implicated_via_orthology) | 2.10e-03 | 26 | 77 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | corpus callosum volume measurement | 2.30e-03 | 100 | 77 | 3 | EFO_0010299 | |
| Disease | ovarian carcinoma (is_marker_for) | 2.43e-03 | 28 | 77 | 2 | DOID:4001 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WLHSVYDKPYADPVH | 691 | Q6ZRH7 | |
| YDKPYADPVHDPTWR | 696 | Q6ZRH7 | |
| KVPWYPSDFLDALHL | 396 | Q96Q91 | |
| DWEVFDPYYFIKHVP | 251 | Q05D32 | |
| LAEYLEAYWKATHPP | 401 | Q02641 | |
| KEYVTLSPDHGYWVL | 366 | Q6UX41 | |
| IPTYALHHDPKYWTE | 396 | P20815 | |
| LHHDPKYWTEPEEFR | 401 | P20815 | |
| DSCPYLSILALHWYP | 5741 | Q8WXG9 | |
| HWKSEDLAYVPYYLD | 231 | Q4W4Y0 | |
| HPEQWDLDYSLEPYT | 726 | Q9NQ90 | |
| KLTESLHEVYEPDWY | 76 | P49418 | |
| VWSPYHSIPDAKLDE | 31 | Q9P2K3 | |
| VWALIADTPYHLYPA | 51 | Q9Y342 | |
| DYYHAIPWLEEAVSL | 196 | Q7Z4N8 | |
| YDYWIDADSPDIHPV | 516 | Q96JM7 | |
| KLLEKHDPWPAYVTY | 21 | Q8N9R6 | |
| LRHPYITVWYDPAEA | 316 | P45984 | |
| KWYEDLIPSAYFPHS | 476 | Q96EY7 | |
| PYDVLPDWLKDNDYL | 96 | Q96A54 | |
| PHTEVFPYILADDKW | 136 | Q99435 | |
| DYTWHPIYPQKADEQ | 661 | Q2LD37 | |
| DIPDPEELDWGSKYY | 1101 | A9Z1Z3 | |
| IPSYALHRDPKYWTE | 396 | P08684 | |
| LKEEHPWVDYTAPSL | 266 | Q14232 | |
| EEAPPRAQHSYKYWL | 751 | Q9H6A9 | |
| PVSHWKPEAVQYYED | 186 | Q96HS1 | |
| DGFRWDYLYKVPTPH | 36 | Q9UJA9 | |
| KEYPPAHIEWLDDTS | 146 | Q53F19 | |
| QWKPLYPDDYVHISS | 131 | Q86TH1 | |
| SSLEWEPEPHLYRSK | 1781 | Q8NEV8 | |
| YVTVEAAPYWLHKPQ | 326 | P32004 | |
| KYDYWVEADSPDIHP | 336 | Q8NA19 | |
| WDQHLYSSDPLYVPD | 246 | Q96RT8 | |
| TEIPWLYYILHPNED | 1096 | Q86XP1 | |
| KCDHYWPFTEEPIAY | 1046 | Q16827 | |
| TYKLWHLDPDTEYEI | 341 | Q92729 | |
| VPIYALHHDPKYWTE | 396 | Q9HB55 | |
| TEGKPHLWELPTDFY | 601 | Q92562 | |
| VAYSLPDWYIHHSKP | 96 | Q8NEG2 | |
| DSHTLPEEWKYLPFL | 46 | Q8NBF6 | |
| LSWSEHLFAPKEIPY | 2361 | Q5VT06 | |
| LLHPRWPESLMYVYE | 6 | P31276 | |
| QGSYPPLLLKAWDHY | 566 | Q8TF76 | |
| HDPSAPDYLEYDIEW | 271 | Q9UK59 | |
| PEYVWVHEKAKYSTP | 271 | Q13206 | |
| IPSYVLHHDPKYWTE | 396 | P24462 | |
| FDTDEYRPPVWKSYL | 6 | P15882 | |
| YPDEEGPKHWSDSRY | 126 | Q8NBJ5 | |
| TYYAVWPDPDLVHDD | 1941 | Q9NZJ4 | |
| GEKYRWPHTIPYVLE | 66 | Q16820 | |
| PTYKLWHLDPDTEYE | 346 | Q15262 | |
| HYRYEDHSPWDPLKD | 706 | Q9H0X9 | |
| FSLLNPDPKSHDVYW | 231 | Q96S52 | |
| PYLPLVTDEDSWYSK | 236 | Q59EK9 | |
| TAKWSYLYPLATHIP | 211 | Q9UGT4 | |
| YTLTPYIHPHPKDWV | 36 | Q86VP1 | |
| HAPYYKLGETTLEEW | 636 | Q9Y4C2 | |
| YELAHPPEEWKYELR | 111 | Q05397 | |
| PPEFYEHAKALWEDE | 786 | Q5JWF2 | |
| SPELVTHLKWDDPYY | 51 | Q07960 | |
| HDPPPWTKYVEYTFT | 151 | Q14524 | |
| LYKDVILVAWDPAPY | 361 | Q96JF0 | |
| PIWDKTIPYDGESFH | 81 | Q10587 | |
| EKAEYEERWPFHPCY | 651 | Q13018 | |
| SPAEEKLPHIDEYWS | 1981 | Q8NFU7 | |
| SPEEYKSYSPEALWR | 871 | Q96JI7 | |
| SHSTPIEWYPDYEVE | 236 | A0A494C1R9 | |
| EYRASHSTPIEWYPD | 226 | P0CW01 | |
| HSTPIEWYPDYEVEA | 231 | P0CW01 | |
| EYRASHSTPIEWYPD | 226 | A6NKD2 | |
| HSTPIEWYPDYEVEA | 231 | A6NKD2 | |
| SHSTPIEWYPDYEVE | 236 | P0CV99 | |
| EYRASHSTPIEWYPD | 226 | Q01534 | |
| HSTPIEWYPDYEVEA | 231 | Q01534 | |
| LETSHKYESWGPLYI | 166 | Q9Y5A6 | |
| YKDWEDPNGETPAYH | 2771 | Q8IZQ1 | |
| YRLDVGWPKHPEYFT | 46 | Q5JS37 | |
| SISGHPYLPEKYWLS | 76 | Q8NCR6 | |
| PYLPEKYWLSQEEAD | 81 | Q8NCR6 | |
| YVLVLDPHYWGTPKS | 86 | Q6NVU6 | |
| KESIPRWYYNPFSEH | 401 | O43278 | |
| EAESHTLTYPPELWY | 391 | Q9NWM0 | |
| SVHYIRENYPLPWEK | 96 | P80108 | |
| PVPDYVAHPERWTKY | 151 | Q9Y5U2 | |
| HPVYSLYFPEEKQEW | 636 | Q9UGP8 | |
| YPYDHWSDKILPVYE | 481 | Q13472 | |
| EYRASHSTPIEWYPD | 226 | P0CV98 | |
| HSTPIEWYPDYEVEA | 231 | P0CV98 | |
| PDIEVHTYPFGWYQK | 2051 | P01266 | |
| AIDAWAPYLPQYIDH | 1046 | Q9Y4E6 | |
| ILYPHEAPSWTLAKD | 1021 | Q96QT4 | |
| TWDPVKDPELLGYYI | 621 | Q5VTT5 |